Comparison of a Multiple Daily Insulin Injection Regimen (Glargine or Detemir Once Daily Plus Prandial Insulin Aspart) and Continuous Subcutaneous Insulin Infusion (Aspart) in Short-Term Intensive Insulin Therapy for Poorly Controlled Type 2 Diabetes Patients

Aims. To examine the potential differences between multiple daily injection (MDI) regimens based on new long-acting insulin analogues (glargine or detemir) plus prandial insulin aspart and continuous subcutaneous insulin aspart infusion (CSII) in patients with poorly controlled type 2 diabetes. Meth...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lv, Wen-shan, Li, Li, Wen, Jun-ping, Pan, Rong-fang, Sun, Rui-xia, Wang, Jing, Xian, Yu-xin, Cao, Cai-xia, Gao, Yan-yan
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2013
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3662171/
https://ncbi.nlm.nih.gov/pubmed/23737776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/614242
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires